文献速递关节外科

HOOS/KOOS疼痛与功能子量表在全髋/全膝置换临床试验中的验证

Validation of the Hip Disability and Osteoarthritis Outcome Score and Knee Injury and Osteoarthritis Outcome Score Pain and Function Subscales for Use in Total Hip Replacement and Total Knee Replacement Clinical Trials.
PubMed 文献 · J Arthroplasty · 2019-12-27

该研究基于4796例单侧全膝置换和4801例单侧全髋置换患者,验证HOOS/KOOS疼痛与ADL功能子量表的构念效度,并与生活质量改善锚定得出MCID和RID阈值。结果显示两子量表与健康相关生活质量相关,效应量大,可作为全关节置换试验的核心测量工具。

要点

  • HOOS/KOOS疼痛与ADL功能子量表在THR/TKR后2年与QOL相关,效度良好。
  • 疼痛MCID≥20、RID≥29;功能MCID≥14、RID≥23(锚定QOL改善)。
  • 两子量表对变化反应敏感,效应量≥1.8,且免费简短,适合核心测量集。

核心结论

  • HOOS/KOOS疼痛与ADL功能子量表是THR/TKR后以患者为中心关键领域的有效测量工具,且具有锚定QOL改善的可达阈值。

研究设计与样本

  • 评估4796例原发性单侧TKR和4801例原发性单侧THR患者基线与2年HOOS/KOOS疼痛和功能。
  • 构念效度用Spearman相关系数分析HOOS/KOOS疼痛与ADL功能同QOL、满意度等的相关性。
  • 以QOL改善为锚,MCID对应「轻度改善」,RID对应「中度改善」。
  • 疼痛与ADL功能评分按四分位数用Kruskal-Wallis比较。

主要发现

  • 2年HOOS/KOOS疼痛与ADL功能同健康相关QOL相关(KOOS疼痛与SF-12 PCS ρ=0.54;功能ρ=0.63)。
  • 按疼痛和功能四分位比较QOL,最高疼痛缓解和功能水平与最大QOL改善相关。
  • 量表的效应量≥1.8,对变化反应敏感。

关键数值与推荐

  • 疼痛MCID估计≥20,RID≥29。
  • 功能MCID≥14,RID≥23。
  • KOOS疼痛与SF-12 PCS相关系数ρ=0.54,功能ρ=0.63。
  • 效应量≥1.8。

临床怎么用

  • 在全髋/全膝置换临床试验中,可用HOOS/KOOS疼痛与ADL功能子量表作为核心测量集。
  • 解读变化时,可参考疼痛MCID≥20、RID≥29,功能MCID≥14、RID≥23(锚定QOL改善)。
  • 量表免费且简短,便于临床研究和随访应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total hip replacement (THR)/total knee replacement (TKR) studies do not uniformly measure patient centered domains, pain, and function. We aim to validate existing measures of pain and function within subscales of standard instruments to facilitate measurement. METHODS: We evaluated baseline and 2-year pain and function for THR and TKR using Hip disability and Osteoarthritis Outcome Score (HOOS)/Knee Injury and Osteoarthritis Outcome Score (KOOS), with primary unilateral TKR (4796) and THR (4801). Construct validity was assessed by correlating HOOS/KOOS pain and activities of daily living (ADL), function quality of life (QOL), and satisfaction using Spearman correlation coefficients. Patient relevant thresholds for change in pain and function were anchored to improvement in QOL; minimally clinically important difference (MCID) corresponded to "a little improvement" and a really important difference (RID) to a "moderate improvement." Pain and ADL function scores were compared by quartiles using Kruskal-Wallis. RESULTS: Two-year HOOS/KOOS pain and ADL function correlated with health-related QOL (KOOS pain and Short Form 12 Physical Component Scale ρ = 0.54; function ρ = 0.63). Comparing QOL by pain and function quartiles, the highest levels of pain relief and function were associated with the most improved QOL. MCID for pain was estimated at ≥20, and the RID ≥29; MCID for function ≥14, and the RID ≥23. The measures were responsive to change with large effect sizes (≥1.8). CONCLUSION: We confirm that HOOS/KOOS pain and ADL function subscales are valid measures of critical patient centered domains after THR/TKR, and achievable thresholds anchored to improved QOL. Cost-free availability and brevity makes them feasible, to be used in a core measurement set in total joint replacement trials.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Goodman SM, Mehta BY, Mandl LA, et al. Validation of the Hip Disability and Osteoarthritis Outcome Score and Knee Injury and Osteoarthritis Outcome Score Pain and Function Subscales for Use in Total Hip Replacement and Total Knee Replacement Clinical Trials. J Arthroplasty. 2019. PMID: 31952945. doi:10.1016/j.arth.2019.12.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。